Harrow, Inc.

Contributing Author

Recent Articles by Harrow, Inc.

Mar-24	Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 HROW GlobeNewswire
Mar-24	Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth HROW GlobeNewswire
Mar-18	Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting HROW GlobeNewswire
Mar-04	Harrow to Present at Leerink Partner's 2026 Global Healthcare Conference HROW GlobeNewswire
Mar-03	Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication HROW -27.96% GlobeNewswire
Mar-02	Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance HROW GlobeNewswire
Feb-18	Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 HROW GlobeNewswire
Feb-17	Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack Kits HROW +5.98% GlobeNewswire
Feb-02	Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270-$280 Million, Marking Another Year of Strong Growth HROW +9.67% GlobeNewswire
Nov-24	Harrow to Present at Two Investor Conferences in December HROW GlobeNewswire
Nov-18	Harrow Announces Closing of Acquisition of Melt Pharmaceuticals HROW GlobeNewswire
Nov-10	Harrow Announces Third Quarter 2025 Financial Results HROW +13.47% HROW GlobeNewswire
Oct-27	Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 HROW GlobeNewswire
Oct-06	ImprimisRx Announces Leadership Changes HROW -7.20% GlobeNewswire
Sep-26	Harrow to Acquire Melt Pharmaceuticals HROW GlobeNewswire
Sep-25	Harrow Launches Harrow Access for All (HAFA) HROW GlobeNewswire
Sep-15	Harrow Announces Agenda and Speakers for Investor & Analyst Day HROW +8.63% GlobeNewswire
Sep-08	Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030 HROW +7.52% GlobeNewswire
Sep-08	Harrow Announces Offering of $250.0 Million Senior Unsecured Notes Due 2030 HROW +7.52% GlobeNewswire
Aug-11	Harrow Announces Second-Quarter 2025 Financial Results HROW GlobeNewswire
Aug-06	Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference HROW GlobeNewswire
Jul-29	Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 HROW GlobeNewswire

Harrow, Inc.

Recent Articles by Harrow, Inc.

Upgrade your FINVIZ experience